Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Hosp Infect ; 67(2): 114-20, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17900757

RESUMO

We report the largest documented healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus (PVL(+) MRSA) in Europe. Six index patients from three long-term care facilities (LTCFs) were screened positive for PVL(+) MRSA in 2004 on admission to a community hospital in Germany. The purpose of this prospective study was to describe the prevalence of PVL(+) MRSA in the LTCFs before and after infection control interventions. Screening for MRSA with or without PVL was performed in all three LTCFs in 2004 [453 residents, 240 healthcare workers (HCWs)] and 2005 (440 residents, 192 HCWs). Swabs from anterior nares and wounds, if applicable, were collected. Colonised residents and staff were treated with mupirocin nasal ointment and topical antiseptics, and staff were provided with hygiene education. Total MRSA carrier rate of residents and HCWs in 2004 was 11.3% (PVL(+) MRSA 9.1%, PVL(-) MRSA 2.2%). There were comparable carrier rates between residents and HCWs in each LTCF. All PVL(+) MRSA isolates were of clonal origin (MLST 22) representing a novel spa sequence type t310. A decrease in total MRSA prevalence (from 11.3 to 5.5%) and PVL(+) MRSA (from 9.1 to 3.3%) was observed in 2005. The rate of PVL(-) MRSA remained unaffected. No symptomatic skin infections were noted among residents or HCWs. In this outbreak incomplete control of PVL(+) MRSA presumably resulted from difficult and delayed detection and decolonisation of carriers, incomplete compliance with control measures and lack of enforcement by public health authorities.


Assuntos
Toxinas Bacterianas/biossíntese , Portador Sadio/tratamento farmacológico , Infecção Hospitalar/epidemiologia , Surtos de Doenças , Exotoxinas/biossíntese , Leucocidinas/biossíntese , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/fisiologia , Administração Intranasal , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Infecção Hospitalar/microbiologia , Feminino , Alemanha/epidemiologia , Fidelidade a Diretrizes , Pessoal de Saúde , Humanos , Controle de Infecções/métodos , Masculino , Resistência a Meticilina , Pessoa de Meia-Idade , Mupirocina/uso terapêutico , Nariz/microbiologia , Pacientes , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/isolamento & purificação , Ferimentos e Lesões/microbiologia
2.
Berl Munch Tierarztl Wochenschr ; 116(7-8): 288-92, 2003.
Artigo em Alemão | MEDLINE | ID: mdl-12894682

RESUMO

Mycobacterial strains from different outbreaks of tuberculosis of cattle in Germany from 1996 to 2001 were differentiated by two molecular biological methods (Spoligotyping, RFLP IS6110). The causative agent was in one case Mycobacterium (M.) africanum, in 10 cases M. bovis and in 17 cases M. bovis ssp. caprae, respectively. The results of the molecular biological methods are discussed from the perspective of epizootiology and the particular importance of infections by M. bovis ssp. caprae emphasized. Direct contact of the animals, purchase from infected stocks, infected zoo animals and wildlife, as well as livestock handlers are discussed as possible sources of infection.


Assuntos
Mycobacterium bovis/classificação , Mycobacterium/classificação , Tuberculose Bovina/epidemiologia , Animais , Técnicas de Tipagem Bacteriana/veterinária , Bovinos , DNA Bacteriano/análise , DNA Bacteriano/química , Alemanha Ocidental/epidemiologia , Mycobacterium/genética , Mycobacterium/isolamento & purificação , Mycobacterium bovis/genética , Mycobacterium bovis/isolamento & purificação , Reação em Cadeia da Polimerase/veterinária , Polimorfismo de Fragmento de Restrição , Tuberculose Bovina/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...